| Serial Number | 98615749 |
| Word Mark | CYTEGRITY |
| Filing Date | Monday, June 24, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, September 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 4, 2025 |
| Goods and Services | Custom manufacture of pharmaceuticals based on cell therapy and gene therapy; Custom manufacture of medicine, namely, personalized medicine for others based on unique characteristics and conditions of the patient |
| Goods and Services | Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare |
| Goods and Services | Research and development services relating to viral vectors, cell therapies, gene therapies, and medicines; Development of pharmaceutical preparations, viral vectors, cell therapies, gene therapies, and medicines; Stem cell research services; Stem cell gene therapy services, namely, advanced inducible stable producer technology research services designed specifically for the production of lentiviral vectors; Gene therapy research; Testing, inspection, research or development of pharmaceutical preparations for gene therapy |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 24, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 24, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 24, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CSL Behring Gene Therapy, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Pasadena, CA 91101 |
| Party Name | CSL Behring Gene Therapy, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pasadena, CA 91101 |
| Event Date | Event Description |
| Monday, June 24, 2024 | NEW APPLICATION ENTERED |
| Monday, January 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 14, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, January 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 29, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 1, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, September 24, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 24, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, September 24, 2025 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 24, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 4, 2025 | PUBLISHED FOR OPPOSITION |